Dr. Douville is an executive with significant entrepreneurial experience in the biotechnology and pharmaceutical industries. He is a founder and the Chief Executive Officer of Milestone Pharmaceuticals Inc. While at Milestone, he raised $34 million in several rounds of equity financing with top tier life sciences venture capital firms to advance Milestone’s lead program from discovery to the clinic. Dr. Douville has been a member of Milestone’s Board of Directors since the company’s inception in 2005 and briefly served as Chairman from 2011 to 2012.  Prior to Milestone Pharmaceuticals, he held the positions of CEO and Chief Business Officer at Galileo Genomics (later Genizon Biosciences), a population genomics company he co-founded. He negotiated Galileo’s seminal deal with Myriad Genetics that provided Galileo’s initial round of financing and subsequently, as Chief Business Officer, he played a key role in preparing the company for its successful $16 million Series A financing. Dr. Douville has also been involved in other biotech start-ups. He has a Ph.D. in Neuroscience from McGill University and an MBA from the HEC business school of the University of Montreal.